These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9289778)

  • 1. [Drug of the month. Fluvastatin (Lescol)].
    Scheen AJ
    Rev Med Liege; 1997 Jun; 52(6):442-4. PubMed ID: 9289778
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvastatin versus pravastatin.
    Chilton R
    Am J Cardiol; 1996 Jul; 78(1):127. PubMed ID: 8712106
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluvastatin for lowering cholesterol.
    Med Lett Drugs Ther; 1994 May; 36(923):45-6. PubMed ID: 8177137
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency of creatine kinase elevation during treatment with fluvastatin.
    Benghozi R; Bortolini M; Jia Y; Isaacsohn JL; Troendle AJ; Gonasun L
    Am J Cardiol; 2002 Jan; 89(2):231-3. PubMed ID: 11792351
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.
    Zavoral JH; Haggerty BJ; Winick AG; Bergmann SD
    Am J Cardiol; 1995 Jul; 76(2):37A-40A. PubMed ID: 7604795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluvastatin on human biliary lipids.
    Tazuma S; Ohya T; Mizuno T; Takizawa I; Kunita T; Takata K; Hayashi K; Hino F; Tokumo H; Watanabe T
    Am J Cardiol; 1995 Jul; 76(2):110A-113A. PubMed ID: 7604783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
    Peters TK
    Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.
    Smit JW; Jansen GH; de Bruin TW; Erkelens DW
    Am J Cardiol; 1995 Jul; 76(2):126A-128A. PubMed ID: 7604787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome monitoring of fluvastatin in a Department of Veterans Affairs lipid clinic.
    Kellick KA; Burns K; McAndrew E; Haberl E; Hook N; Ellis A
    Am J Cardiol; 1995 Jul; 76(2):62A-64A. PubMed ID: 7604801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of fluvastatin for hyperlipidemia in Japanese patients.
    Teramoto T; Goto Y; Kurokawa K; Nakamura H; Yoshida S; Saito Y; Nakaya N; Itakura H; Takaku F; Yamada N
    Am J Cardiol; 1995 Jul; 76(2):33A-36A. PubMed ID: 7604794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemia.
    Fanghänel G; Espinosa J; Olivares D; Sánchez L; Morales M; Martínez L; Macías G; Valdés E; Hernández G
    Am J Cardiol; 1995 Jul; 76(2):57A-61A. PubMed ID: 7604800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group.
    Jacotot B; Banga JD; Waite R; Peters TK
    Am J Cardiol; 1995 Jul; 76(2):41A-46A. PubMed ID: 7604796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
    Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract]   [Full Text] [Related]  

  • 14. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
    MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.
    Eliav O; Schurr D; Pfister P; Friedlander Y; Leitersdorf E
    Am J Cardiol; 1995 Jul; 76(2):76A-79A. PubMed ID: 7604804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.
    Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G
    Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group.
    Jacotot B; Banga JD; Pfister P; Mehra M
    Br J Clin Pharmacol; 1994 Sep; 38(3):257-63. PubMed ID: 7826828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia.
    Rindone JP; Hiller D; Arriola G
    Pharmacotherapy; 1998; 18(4):836-9. PubMed ID: 9692657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.